Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease

European Journal of Endocrinology

Volumn 159, Issue 5, 2008, Pages 533-540

  Davi, Maria Vittoria ^a   Dalle Carbonare, Luca ^a   Giustina, Andrea ^b   Ferrari, Marcello ^a   Frigo, Anna ^a   Lo Cascio, Vincenzo ^a   Francia, Giuseppe ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ACROMEGALY; ADULT; AGE DISTRIBUTION; ARTICLE; BIOCHEMISTRY; BODY MASS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE DURATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; ITALY; LONGITUDINAL STUDY; MALE; POLYSOMNOGRAPHY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REMISSION; REPEAT PROCEDURE; RISK ASSESSMENT; SEX DIFFERENCE; SLEEP APNEA SYNDROME;

ACROMEGALY; ADENOMA; ADULT; AGED; COMBINED MODALITY THERAPY; COMORBIDITY; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INSULIN-LIKE GROWTH FACTOR I; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; SLEEP APNEA SYNDROMES; SOMATOSTATIN;

EID: 56749156655     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0442     Document Type: Article

References (38)

1. Grunstein RR, Ho KY & Sullivan CE. Sleep apnea in acromegaly. Annals of Internal Medicine 1991 115 527-532.
2. Fatti LM, Sacchi M, Pincelli AI, Lavezzi E & Cavagnini F. Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary 2001 4 259-262.
3. Weiss V, Sonka K, Pred M, Dostalova S, Klozar J, Kambousek P, Marek J & Haas T. Prevalence of the sleep apnea syndrome in acromegaly population. Journal of Endocrinological Investigation 2000 23 515-519.
4. Pekkarinen T, Partinen M, Pelkonen R & Iivanainen M. Sleep apnoea and daytime sleepiness in acromegaly: relationship to endocrinological factors. Clinical Endocrinology 1987 27 649-654.
5. Hochban W, Ehlenz K, Conradt R & Brandenburg U. Obstructive sleep apnoea in acromegaly: the role of craniofacial changes. European Respiratory Journal 1999 14 196-202.
6. Giustina A, Casanueva FF, Cavagnini F, Chanson P, Clemmons D, Frohman LA, Gaillard R, Ho K, Jaquet P, Kleinberg DL, Lamberts SW, Lombardi G, Sheppard M, Strasburger CJ, Vance ML, Wass JA & Melmed S. Consensus: diagnosis and treatment of acromegaly complications. Journal of Endocrinological Investigation 2003 26 1242-1247.
7. Colao A, Ferone D, Marzullo P & Lomabardi G. Systemic complications of acromegaly: epidemiology, pathogenesis and management. Endocrine Reviews 2004 25 102-152.
8. Patil SP, Schneider H, Schwartz AR & Smith PL. Adult obstructive sleep apnea: pathophysiology and diagnosis. Chest 2007 132 325-337.
9. Marin JM, Carrizo SJ, Vincente E & Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apneahypopnoea with or without treatment with continous positive airway pressure: an observational study. Lancet 2005 365 1046-1053.
10. Shamsuzzaman AS, Gersh BJ & Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. Journal of the American Medical Association 2003 290 1906-1914.
11. Yaggi HK, Concato J, Kerman WN, Lichtman JH, Brass LM & Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. New England Journal of Medicine 2005 353 2034-2041.
12. Perks WH, Horrocks PM, Cooper RA, Bradbury S, Allen A, Baldock N, Prowse K & van't Hoff W. Sleep apnoea in acromegaly. BMJ 1980 280 894-897.
13. Hart TB, Radow SK, Blackard WG, Tucker HS & Cooper KR. Sleep apnoea in active acromegaly. Archives of Internal Medicine 1985 145 865-866.
14. Rosenow F, Reuter S, Deuss U, Szelies B, Hilgers RD, Winkelmann W & Heiss WDI. Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clinical Endocrinology 1996 45 563-569.
15. Dostalova S, Sonka K, Smahel Z, Weiss V, Marek J & Horinek D. Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly. European Journal of Endocrinology 2001 144 491-497.
16. Herrmann BL, Wessendorf TE, Ajaj W, Kahlke S, Teschler H & Mann K. Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. European Journal of Endocrinology 2004 151 309-315.
17. Van Haute FR, Taboada GF, Corrêa LL, Lima GA, Fontes R, Riello AP, Dominaci M & Gadelha MR. Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging. European Journal of Endocrinology 2008 158 459-465.
18. Sze L, Schmid C, Bloch KE, Bernays R & Brandle M. Effect of transsphenoidal surgery on sleep apnoea in acromegaly. European Journal of Endocrinology 2007 156 321-329.
19. Isono S, Saeki N, Tanaka A & Nishino T. Collapsibility of passive pharynx in patients with acromegaly. American Journal of Respiratory and Critical Care Medicine 1999 160 64-68.
20. Ip MSM, Tan KCB, Peh WCG & Lam KSL. Effects of Sandostatin Lar on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity. Clinical Endocrinology 2001 55 477-483.
21. Mickelson SA, Rosenthal LD, Rock JP, Senior BA & Friduss ME. Obstructive sleep apnea syndrome and acromegaly. Archives of Otolaryngology - Head & Neck Surgery 1994 111 25-30.
22. Main G, Borsey DQ & Newton RW. Successful reversal of sleep apnoca syndrome following treatment for acromegaly, confirmed by polygraphic studies. Postgraduate Medical Journal 1988 64 945-946.
23. Piper JG, Dirks BA, Traynelis VC & VanGilder JC. Perioperative management and surgical outcome of the acromegalic patient with sleep apnea. Neurosurgery 1995 36 70-74; discussion 74-75.
24. Pelttari L, Polo O, Rauhala E, Vuoriluoto J, Aitasalo K, Hyyppa MT, Kronholm E, Irjala K & Viikari J. Nocturnal breathing abnormalities in acromegaly after adenomectomy. Clinical Endocrinology 1995 43 175-182.
25. Saeki N, Isono S, Nishino T, Iuchi T & Yamaura A. Sleep-disordered breathing in acromegalics-relation of hormonal levels and quantative sleep study by means of bedside oximeter. Endocrine Journal 1999 46 585-590.
26. Tolis G, Angelopoulos NG, Katounda E, Rombopoulos G, Kaltzidou V, Kaltsas D, Protonotariou A & Lytras A. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs. Neuroendocrinology 2006 83 249-257.
27. Buyse B, Michiels E, Bouillon R, Bobbaers H & Demedts M. Relief of sleep apnoea after treatment of acromegaly: report of three cases and review of the literature. European Respiratory Journal 1997 10 1401-1404.
28. Grunstein RR, Ho KK & Sullivan CE. Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly. Annals of Internal Medicine 1994 121 478-483.
29. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K & Melmed S. Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2000 85 526-529.
30. American Academy of Sleep Medicine Task Force Report. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999 22 667-689.
31. Sahn DJ, DeMaria A, Kisslo J & Weyman A. The committee on M-mode standardization of the America Society of Echocardio-graphy. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiography measurements. Circulation 1978 58 1072-1083.
32. Devereux RB & Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977 55 613-618.
33. De Marinis L, Bianchi A, Mazziotti G, Mettimano M, Milardi D, Fusco A, Cimino V, Maira G, Pontecorvi A & Giustina A. The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. Pituitary 2008 11 13-20.
34. Young T, Skatrud J & Peppard PE. Risk factors for obstructive sleep apnea in adults. Journal of the American Medical Association 2004 291 2013-2016.
35. Tishler PV, Larkin EK, Schluchter MD & Redline S. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. Journal of the American Medical Association 2003 289 2230-2237.
36. Punjabi NM & Polotsky VY. Disorders of glucose metabolism in sleep apnea. Journal of Applied Physiology 2005 99 1998-2007.
37. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ & Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clinical Endocrinology 1994 41 95-102.
38. Wolk R & Somers VK. Cardiovascular consequences of obstructive sleep apnea. Clinics in Chest Medicine 2003 24 195-205.